Iovance Biotherapeutics, Inc. (IOVA)

Last Closing Price: 14.10 (2024-03-27)

Operating Expenses (Quarterly)

Operating Expenses: The sum of all operating expenses for the given industry.

Iovance Biotherapeutics, Inc. (IOVA) had Operating Expenses of $121.74M for the most recently reported fiscal quarter, ending 2023-12-31.

Figures for fiscal quarter ending 2023-12-31
Income Statement Financials
$0.48M
$-116.38M
$4.37M
$-3.88M
Operating Expenses
$121.74M
$-121.26M
$3.12M
$-118.14M
$-118.14M
$-116.38M
$-116.38M
$-116.38M
$-116.38M
$-121.26M
$-113.27M
235.13M
235.13M
$-0.46
$-0.46
Balance Sheet Financials
$307.85M
$114.03M
$472.50M
$780.35M
$110.31M
$1.00M
$85.43M
$195.74M
$584.61M
$355.36M
$584.61M
256.14M
Cash Flow Statement Financials
$-361.82M
$-155.24M
$462.96M
$238.16M
$181.32M
$-56.84M
$62.62M
--
--
Fundamental Metrics & Ratios
2.79
--
--
0.00
0.00
-805.60%
-25156.84%
-25156.85%
--
-24509.96%
-24145.02%
$-384.11M
--
--
--
0.00
0.42
3.19
28.20
-19.91%
-32.75%
-14.91%
-19.87%
$2.28
$-1.63
$-1.54